Cas:205688-52-4 5-AMINOISATOIC ANHYDRIDE manufacturer & supplier

We serve Chemical Name:5-AMINOISATOIC ANHYDRIDE CAS:205688-52-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-AMINOISATOIC ANHYDRIDE

Chemical Name:5-AMINOISATOIC ANHYDRIDE
CAS.NO:205688-52-4
Synonyms:5-AMINOISATOIC ANHYDRIDE
Molecular Formula:C8H6N2O3
Molecular Weight:178.14
HS Code:

Physical and Chemical Properties:
Melting point:>300 °C(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 3
Packing Group:


Contact us for information like 5-AMINOISATOIC ANHYDRIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-AMINOISATOIC ANHYDRIDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-AMINOISATOIC ANHYDRIDE Use and application,5-AMINOISATOIC ANHYDRIDE technical grade,usp/ep/jp grade.


Related News: However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 5-AMINOISATOIC ANHYDRIDE manufacturer Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.�� 5-AMINOISATOIC ANHYDRIDE supplier That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 5-AMINOISATOIC ANHYDRIDE vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 5-AMINOISATOIC ANHYDRIDE factory Our previous work with Retrogenix validated their technology as a uniquely powerful approach for antibody target deconvolution, and we look forward to working with Retrogenix to enhance our growing pipeline of antibody candidates.��